[ Arsanis raises $45.5M in Series D ]

Arsanis has raised $45.5 million in Series D funding.

Founded in 2010, Arsanis is a biosciences company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.

Arsanis has about 30 employees at a research office in Vienna. The rest are located at the corporate headquarters in Waltham.

Funding  Series D
Founded  2010
Country  Austria
City  Vienna, Wien
Founder / CEO  Renè Russo
Deal Size  $45.5M
Investors  Bill & Melinda Gates Foundation
 SV Health Investors
 Polaris Partners
 GV
Previous Investors  Bill & Melinda Gates Foundation
 SV Health Investors
 OrbiMed
 Polaris Partners
 Neomed Management

[adyen action=”checkout_button”]